Your browser doesn't support javascript.
Transmission, viral kinetics and clinical characteristics of the emergent SARS-CoV-2 Delta VOC in Guangzhou, China.
Wang, Yaping; Chen, Ruchong; Hu, Fengyu; Lan, Yun; Yang, Zhaowei; Zhan, Chen; Shi, Jingrong; Deng, Xizi; Jiang, Mei; Zhong, Shuxin; Liao, Baolin; Deng, Kai; Tang, Jingyan; Guo, Liliangzi; Jiang, Mengling; Fan, Qinghong; Li, Meiyu; Liu, Jinxin; Shi, Yaling; Deng, Xilong; Xiao, Xincai; Kang, Min; Li, Yan; Guan, Weijie; Li, Yimin; Li, Shiyue; Li, Feng; Zhong, Nanshan; Tang, Xiaoping.
  • Wang Y; Guangzhou Eighth People's Hospital , Guangzhou Medical University, Guangzhou, 510060, China.
  • Chen R; State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Laboratory, Bio-Island, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, China.
  • Hu F; Department of Allergy and Clinical Immunology, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, China.
  • Lan Y; Guangzhou Eighth People's Hospital , Guangzhou Medical University, Guangzhou, 510060, China.
  • Yang Z; Guangzhou Eighth People's Hospital , Guangzhou Medical University, Guangzhou, 510060, China.
  • Zhan C; State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Laboratory, Bio-Island, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, China.
  • Shi J; Department of Allergy and Clinical Immunology, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, China.
  • Deng X; State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Laboratory, Bio-Island, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, China.
  • Jiang M; Department of Allergy and Clinical Immunology, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, China.
  • Zhong S; Guangzhou Eighth People's Hospital , Guangzhou Medical University, Guangzhou, 510060, China.
  • Liao B; Guangzhou Eighth People's Hospital , Guangzhou Medical University, Guangzhou, 510060, China.
  • Deng K; State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Laboratory, Bio-Island, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, China.
  • Tang J; State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Laboratory, Bio-Island, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, China.
  • Guo L; Guangzhou Eighth People's Hospital , Guangzhou Medical University, Guangzhou, 510060, China.
  • Jiang M; Guangzhou Eighth People's Hospital , Guangzhou Medical University, Guangzhou, 510060, China.
  • Fan Q; Guangzhou Eighth People's Hospital , Guangzhou Medical University, Guangzhou, 510060, China.
  • Li M; Guangzhou Eighth People's Hospital , Guangzhou Medical University, Guangzhou, 510060, China.
  • Liu J; Guangzhou Eighth People's Hospital , Guangzhou Medical University, Guangzhou, 510060, China.
  • Shi Y; Guangzhou Eighth People's Hospital , Guangzhou Medical University, Guangzhou, 510060, China.
  • Deng X; Guangzhou Eighth People's Hospital , Guangzhou Medical University, Guangzhou, 510060, China.
  • Xiao X; Guangzhou Eighth People's Hospital , Guangzhou Medical University, Guangzhou, 510060, China.
  • Kang M; Guangzhou Eighth People's Hospital , Guangzhou Medical University, Guangzhou, 510060, China.
  • Li Y; Guangzhou Eighth People's Hospital , Guangzhou Medical University, Guangzhou, 510060, China.
  • Guan W; Guangzhou Chest Hospital, Guangzhou Medical University, Guangzhou 510095, China.
  • Li Y; Guangdong Provincial Center for Disease Control and Prevention, Guangzhou 511430, China.
  • Li S; Guangdong Provincial Center for Disease Control and Prevention, Guangzhou 511430, China.
  • Li F; State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Laboratory, Bio-Island, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, China.
  • Zhong N; State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Laboratory, Bio-Island, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, China.
  • Tang X; State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Laboratory, Bio-Island, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, China.
EClinicalMedicine ; 40: 101129, 2021 Oct.
Article in English | MEDLINE | ID: covidwho-1401440
ABSTRACT

BACKGROUND:

A novel variant of SARS-CoV-2, the Delta variant of concern (VOC, also known as lineage B.1.617.2), is fast becoming the dominant strain globally. We reported the epidemiological, viral, and clinical characteristics of hospitalized patients infected with the Delta VOC during the local outbreak in Guangzhou, China.

METHODS:

We extracted the epidemiological and clinical information pertaining to the 159 cases infected with the Delta VOC across seven transmission generations between May 21 and June 18, 2021. The whole chain of the Delta VOC transmission was described. Kinetics of viral load and clinical characteristics were compared with a cohort of wild-type infection in 2020 admitted to the Guangzhou Eighth People's Hospital.

FINDINGS:

There were four transmission generations within the first ten days. The Delta VOC yielded a significantly shorter incubation period (4.0 vs. 6.0 days), higher viral load (20.6 vs. 34.0, cycle threshold of the ORF1a/b gene), and a longer duration of viral shedding in pharyngeal swab samples (14.0 vs. 8.0 days) compared with the wild-type strain. In cases with critical illness, the proportion of patients over the age of 60 was higher in the Delta VOC group than in the wild-type strain (100.0% vs. 69.2%, p = 0.03). The Delta VOC had a higher risk than wild-type infection in deterioration to critical status (hazards ratio 2.98 [95%CI 1.29-6.86]; p = 0.01).

INTERPRETATION:

Infection with the Delta VOC is characterized by markedly increased transmissibility, viral loads and risk of disease progression compared with the wild-type strain, calling for more intensive prevention and control measures to contain future outbreaks.

FUNDING:

National Grand Program, National Natural Science Foundation of China, Guangdong Provincial Department of Science and Technology, Guangzhou Laboratory.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Cohort study / Observational study / Prognostic study Topics: Variants Language: English Journal: EClinicalMedicine Year: 2021 Document Type: Article Affiliation country: J.eclinm.2021.101129

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Cohort study / Observational study / Prognostic study Topics: Variants Language: English Journal: EClinicalMedicine Year: 2021 Document Type: Article Affiliation country: J.eclinm.2021.101129